'Nothing related to...' Did HDFC Bank get clean chit from RBI? Here's what Guv Sanjay Malhotra said - Markets

‘Nothing related to…’ Did HDFC Bank get clean chit from RBI? Here’s what Guv Sanjay Malhotra said – Markets

Heena Ojha is a Senior Copy Editor at ET Now Digital, where she covers markets, economy, personal finance and economic trends for a wide range of audience. She has experience in fast-paced newsrooms across the nation, she brings a strong background in breaking news reporting, feature writing, fact-checking and multimedia storytelling. She managed coverage of…

Read More
Antony Waste shares gain as Japan’s JFE invests ₹44 crore for 25% stake in two SPVs

Antony Waste shares gain as Japan’s JFE invests ₹44 crore for 25% stake in two SPVs

Antony Waste Handling Cell Ltd. said its subsidiary Antony Lara Enviro Solutions Pvt. Ltd. has entered into agreements with Japan’s JFE Engineering Corporation for an investment of up to ¥750 million (approximately ₹44 crore) in two waste-to-energy projects in Andhra Pradesh. The investment will be made in two special purpose vehicles (SPVs) — Kadapa Renew…

Read More
Apollo Hospitals share price: 4% target cut by Morgan Stanley, brokerage maintains Overweight rating - Markets

Apollo Hospitals share price: 4% target cut by Morgan Stanley, brokerage maintains Overweight rating – Markets

Namit Singh Sengar is a Chief Copy Editor with over seven years of experience in delivering content across diverse domains. Specialising in business news across personal finance, real estate, IPOs and markets, Namit brings an editorial eye and a deep understanding of complex subjects to his work. His educational foundation includes Post Graduate Diploma in…

Read More
Tata Stock To Buy: Titan draws bullish calls as brokerages flag strong demand, 46% Q4 growth in update - Check target price - Markets

Tata Stock To Buy: Titan draws bullish calls as brokerages flag strong demand, 46% Q4 growth in update – Check target price – Markets

Titan Share Price Target, Tata Stock To Buy: Titan Company Ltd attracted a bullish response from global brokerages after the Tata Group firm reported a robust 46 per cent year‑on‑year growth in its consumer businesses for the March quarter business update, beating expectations on domestic jewellery demand. Both Morgan Stanley and Goldman Sachs reiterated their…

Read More
Dr Reddy's Share Price: Healthcare stock target cut by Morgan Stanley - Here's why - Markets

Dr Reddy’s Share Price: Healthcare stock target cut by Morgan Stanley – Here’s why – Markets

Dr Reddy’s Share Price: Global Financial Services, Morgan Stanley has revised its outlook on Dr Reddy’s Laboratories, maintaining an ‘Equal Weight’ rating while lowering the target price to Rs 1,259 due to projected earnings downgrades. Established in 1984, Dr Reddy’s Laboratories is a pharmaceutical company headquartered in Hyderabad, India. It focuses on providing affordable and…

Read More